Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Gut IEL GLP-1R mediates local antiinflammatory actions in the small intestine by inhibiting proximal T cell receptor (TCR) signaling in a protein kinase Adependent manner, reducing phosphorylation of ZAP70 and SLP-76, which are key signaling nodes for initiating TCR-driven cytokine expression (Figure 3)
Control and Ethical Factors: Long-term research with IGF1 LR3 must be conducted within appropriate control and ethical frameworks
Elevated homocysteine levels (which rise when vitamin B12, folic acid, or vitamin B6 are low) have also been associated in observational studies with higher rates of Alzheimers disease and dementia
nejm.org American College of Cardiology
Frequently asked questions What should I do if I miss a dose of tirzepatide